P

Inventor

SHENG XIAOXIA

CN33 patents
⚠️ This page may combine multiple inventors who share the name “SHENG XIAOXIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HANGZHOU SOLIPHARMA CO LTD

18 patents
US10899770B2Jan 26, 2021

Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereof

HANGZHOU SOLIPHARMA CO LTD4 citations72
US11919906B2Mar 5, 2024

Crystal form of ACP-196 and method of treatment thereof

HANGZHOU SOLIPHARMA CO LTD0 citations62
US11286259B2Mar 29, 2022

Co-crystals of ribociclib and co-crystals of ribociclib monosuccinate, preparation method therefor, compositions thereof, and uses thereof

HANGZHOU SOLIPHARMA CO LTD0 citations62
US11236073B2Feb 1, 2022

ODM-201 crystalline form, preparation method therefor, and pharmaceutical composition thereof

HANGZHOU SOLIPHARMA CO LTD0 citations62
US11236077B2Feb 1, 2022

Fruquintinib eutectic crystal, preparation method therefor, composition, and uses thereof

HANGZHOU SOLIPHARMA CO LTD0 citations62
US11208382B2Dec 28, 2021

Entinostat-containing compound, crystal form of compound thereof, and preparation method therefor and pharmaceutical composition thereof

HANGZHOU SOLIPHARMA CO LTD0 citations62
US11111248B2Sep 7, 2021

Crystal form of 2-(6-methyl-pyridin-2-yl)-3-yl-[6-amido-quinolin-4-yl]-5,6-dihydro-4H-pyrrolo[1,2-B]pyrazole, preparation method therefor and pharmaceutical composition thereof

HANGZHOU SOLIPHARMA CO LTD0 citations62
US10995083B2May 4, 2021

Cocrystal of 2-(6-methyl-pyridine-2-yl)-3-yl-[6-amide-quinoline-4-yl]-5,6-dihydro-4H-pyrrole[1,2-b]pyrazole, preparation method therefor, and pharmaceutical composition

HANGZHOU SOLIPHARMA CO LTD0 citations62
US10899767B2Jan 26, 2021

Crystal form of ACP-196, preparation method therefor and pharmaceutical composition thereof

HANGZHOU SOLIPHARMA CO LTD1 citations62
US11117875B2Sep 14, 2021

Crystalline forms, preparation methods and pharmaceutical compositions of ozanimod

HANGZHOU SOLIPHARMA CO LTD0 citations61
US12103925B2Oct 1, 2024

Crystal and amorphous form of tolebrutinib, preparation method therefor, and use thereof

HANGZHOU SOLIPHARMA CO LTD0 citations60
US10954223B2Mar 23, 2021

Canagliflozin monohydrate and its crystalline forms, preparation methods and uses thereof

HANGZHOU SOLIPHARMA CO LTD0 citations60
US10669256B2Jun 2, 2020

Crystalline forms of lasmiditan, preparation methods, pharmaceutical compositions and uses thereof

HANGZHOU SOLIPHARMA CO LTD1 citations58
US11639341B2May 2, 2023

Crystal form of tipifarnib and method of treatment thereof

HANGZHOU SOLIPHARMA CO LTD0 citations57
US10954210B2Mar 23, 2021

Crystal form of tipifarnib and preparation method and pharmaceutical composition thereof

HANGZHOU SOLIPHARMA CO LTD1 citations57
US10759798B2Sep 1, 2020

ABT-199 addition salt and crystal form thereof, preparation method thereof, and pharmaceutical composition thereof

HANGZHOU SOLIPHARMA CO LTD0 citations51
US10675276B2Jun 9, 2020

Dosing preparation of dabigatran etexilate or a salt thereof and a preparation method thereof

HANGZHOU SOLIPHARMA CO LTD0 citations41
US10660963B2May 26, 2020

Pharmaceutical composition containing tacrolimus and preparation methods thereof

HANGZHOU SOLIPHARMA CO LTD0 citations41

HANGZHOU PUSHAI PHARMACEUTICAL TECH CO LTD

9 patents

HANGZHOU PUSHAI PHARMACEUTICAL TECHNOLOGY CO LTD

2 patents

SHENG XIAOXIA

1 patent

BARCLAY MICHAEL

1 patent

UNIV ZHEJIANG TECHNOLOGY

1 patent

CHONG WEN SIN

1 patent